Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

10x Genomics (TXG) Shares Outstanding (2018 - 2025)

Historic Shares Outstanding for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $127.7 million.

  • 10x Genomics' Shares Outstanding rose 441.53% to $127.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $127.7 million, marking a year-over-year increase of 441.53%. This contributed to the annual value of $127.7 million for FY2025, which is 441.53% up from last year.
  • Latest data reveals that 10x Genomics reported Shares Outstanding of $127.7 million as of Q4 2025, which was up 441.53% from $126.5 million recorded in Q3 2025.
  • 10x Genomics' 5-year Shares Outstanding high stood at $127.7 million for Q4 2025, and its period low was $109.6 million during Q1 2021.
  • Over the past 5 years, 10x Genomics' median Shares Outstanding value was $117.8 million (recorded in 2023), while the average stood at $117.9 million.
  • In the last 5 years, 10x Genomics' Shares Outstanding skyrocketed by 1165.96% in 2021 and then surged by 238.19% in 2022.
  • 10x Genomics' Shares Outstanding (Quarter) stood at $112.5 million in 2021, then rose by 2.38% to $115.2 million in 2022, then increased by 3.39% to $119.1 million in 2023, then grew by 2.68% to $122.3 million in 2024, then increased by 4.42% to $127.7 million in 2025.
  • Its Shares Outstanding stands at $127.7 million for Q4 2025, versus $126.5 million for Q3 2025 and $124.4 million for Q2 2025.